BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28958626)

  • 21. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells.
    Lu X; Gao J; Zhang Y; Zhao T; Cai H; Zhang T
    PLoS One; 2018; 13(7):e0198823. PubMed ID: 29985912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
    Jung H; Kim B; Moon BI; Oh ES
    Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.
    Trivanović D; Jauković A; Krstić J; Nikolić S; Okić Djordjević I; Kukolj T; Obradović H; Mojsilović S; Ilić V; Santibanez JF; Bugarski D
    IUBMB Life; 2016 Mar; 68(3):190-200. PubMed ID: 26805406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
    Park IH; Kang JH; Shin JM; Lee HM
    PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes.
    Villar V; Kocic J; Bugarski D; Jovcic G; Santibanez JF
    FEBS Lett; 2010 Nov; 584(22):4586-92. PubMed ID: 20965173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical Chaperone of Endoplasmic Reticulum Stress Inhibits Epithelial-Mesenchymal Transition Induced by TGF-
    Lee HM; Kang JH; Shin JM; Lee SA; Park IH
    Mediators Inflamm; 2017; 2017():8123281. PubMed ID: 28804222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Tyszka-Czochara M; Lasota M; Majka M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
    Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
    Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress.
    Liu Y; Yuan X; Li W; Cao Q; Shu Y
    Int J Mol Med; 2016 Oct; 38(4):1235-42. PubMed ID: 27573422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells.
    Chen MJ; Gao XJ; Xu LN; Liu TF; Liu XH; Liu LX
    Int J Oncol; 2014 Oct; 45(4):1515-22. PubMed ID: 25051016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.
    Fan Z; Jiang H; Wang Z; Qu J
    Oncol Rep; 2016 Aug; 36(2):1016-22. PubMed ID: 27349500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
    Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
    Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D regulating TGF-β induced epithelial-mesenchymal transition.
    Fischer KD; Agrawal DK
    Respir Res; 2014 Nov; 15(1):146. PubMed ID: 25413472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.